U.S. FDA Casts Doubt on Lantus Cancer Link
Reuters -- The U.S. Food and Drug Administration cast doubt on Wednesday on a possible association of cancer with Sanofi-Aventis' widely used Lantus diabetes drug after recently published studies suggested such a link.